Skip to content

A Case Series of Culturally-adapted CBTp for Black People in the UK

Culturally-adapted Cognitive-behavioural Therapy for Black Sub-Saharan African and Caribbean People Experiencing Psychosis: A Case Series

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07252206
Enrollment
6
Registered
2025-11-26
Start date
2026-02-24
Completion date
2026-12-01
Last updated
2026-07-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Psychosis, Schizophrenia Spectrum Disorders

Brief summary

The goal of this case series study is to learn if culturally-adapted cognitive-behavioural therapy is practical, acceptable and safe among Black Sub-Saharan African and Caribbean people experiencing psychosis. The main question it aims to answer is: Is culturally-adapted CBT for psychosis feasible, acceptable to and safe for Black Sub-Saharan African and Caribbean people experiencing psychosis? Participants will be asked to: * Answer some questionnaires about how things are at the moment * Attend up to 16 sessions of therapy * Answer the same questionnaires to see what has changed, if anything * Complete a semi-structured interview about their expectations and experience of therapy

Interventions

BEHAVIORALCulturally-adapted cognitive-behavioural therapy

Cognitive-behavioural therapy for psychosis culturally-adapted for Black Sub-Saharan African and Caribbean people using a dedicated, integrated treatment manual

Sponsors

University of Manchester
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
16 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Service users who identify as Black British, Black Caribbean, Black African, African-Caribbean or Mixed African/Caribbean with at least one parent and/or grandparent born in a Sub-Saharan African or Caribbean country * People with a current ICD-10 schizophrenia spectrum disorder diagnosis, or who are currently receiving or have received support from an Early Intervention in Psychosis team * 16 years or older * Sufficient understanding of English to complete study measures and engage with CBTp

Exclusion criteria

* Current, primary diagnosis of substance use disorder * Organic aetiology of psychosis * Lacking capacity to provide full informed consent * Currently experiencing a mental health crisis (i.e., are open to a home-based treatment team; are currently under Section of the Mental Health Act or have been under Section in the past 3 months) or immediate high risk to self or others (i.e., current suicidal intent or plans; unmanaged and intense non-suicidal self-injury) * Currently receiving CBTp or received CBTp within the preceding 3 months * Unwilling to participate in culturally-adapted CBTp

Design outcomes

Primary

MeasureTime frameDescription
Semi-structured qualitative interview: Service user acceptabilityEnd of therapy (16 weeks)Service user satisfaction as assessed by qualitative interview.

Secondary

MeasureTime frameDescription
Working Alliance Inventory-Short Form RevisedEnd of therapy (16 weeks)Acceptability measured sessionally using the Working Alliance Inventory-Short Form Revised (Hatcher \& Gillaspy, 2006)
Adverse Events ChecklistEach therapy session (16 weeks)Safety monitored sessionally using an Adverse Events Checklist developed for this study
Subjective Experience of Psychosis ScaleEnd of therapy (16 weeks)Subjective distress measured by the Subjective Experience of Psychosis Scale (Haddock et al., 2011)
Questionnaire about the Process of RecoveryEnd of therapy (16 weeks)Perceived recovery measured by the Questionnaire about the Process of Recovery (Law et al., 2014)
Depression, Anxiety and Stress ScalesEnd of therapy (16 weeks)Emotional wellbeing measured by the Depression, Anxiety and Stress Scales (Lovibond \& Lovibond, 1995)

Countries

United Kingdom

Contacts

CONTACTPeter Panayi
peter.panayi@manchester.ac.uk+44161 306 6000

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Jul 11, 2026